Total Funding
90
49
Total FundingVenture - Series Unknown raised
Growth Score
-7 pts
Heat Score
3 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Recent Milestones
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
See more interactive data and historical milestones on desktop for the best experience
2459
Cartography is an oncology company that develops cancer immunotherapies that target novel and highly specific tumor antigens.
- Kevin Parker: Co-Founder and CEO
- Dan Rock: Chief Scientific Officer
About the Company
Cartography is an oncology company that develops cancer immunotherapies that target novel and highly specific tumor antigens. The company provides a differentiated oncology pipeline of antibody-based therapies to target tumors more precisely than existing therapeutics. Its ATLAS and SUMMIT drug discovery platforms are powered by an
industry-leading, fully integrated dataset spanning hundreds of thousands of cell states across the healthy body and large-scale profiling of individual cells from patient tumors.
